Skip to content

Compared rosemary with minoxidil 2% in the treatment of alopecia areata

Compared rosemary with minoxidil 2% in the treatment of alopecia areata

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013022312563N1
Enrollment
78
Registered
2013-04-23
Start date
2012-11-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

alopecia areata. Alopecia areata

Interventions

Intervention 1: In control group used minoxidil2% from Mina Company. The patients use the medicine topically twice daily for period of two months. Intervention 2: The patients in the intervention gro
Treatment - Drugs
In control group used minoxidil2% from Mina Company. The patients use the medicine topically twice daily for period of two months
The patients in the intervention group used rosemary herbal medicine from Goldaroo CompanyThe patients use the medicine topically twice daily for period of two months.

Sponsors

Kurdistan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria Scalp alopecia ; loss of less than 10 cm Exclusion criteria: Pregnancy and breastfeeding; received treatment in the past 2 months; involved the scalp margins ;Rosemary sensitivity

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Improve percent alopecia areata. Timepoint: Alopecia percent improvement. Method of measurement: Before treatment - after treatment (2 months).

Secondary

MeasureTime frame
Drug allergy. Timepoint: Before and After. Method of measurement: Clinical Assessment.

Countries

Iran (Islamic Republic of)

Contacts

Public Contactfardin gharibi

Kurdistan University of Medical Sciences -Deputy of Research

fardin.gharibi@muk.ac.ir+98 87 1613 1281

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026